{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-001461","form_type":"8-K","ticker":"VBIO","cik":"0001787740","company_name":"Valion Bio, Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.184457+00:00","generated_at":"2026-05-15T21:45:34.833398+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tivic Health CEO Jennifer Ernst resigns; Michael Handley appointed CEO to lead biopharma pivot","bullets":["CEO Jennifer Ernst resigned March 2, 2026; board departure effective March 5; separation includes $325K cash severance, COBRA, equity vesting, and $50K restricted stock.","Michael Handley appointed CEO and board member effective March 3; previously COO and President of Tivic Biopharma since February 2025.","Handley brings over 20 years life sciences experience; led commercialization of 17 products, worked at Amgen and Genentech.","Company shifts strategic focus to late-stage immunotherapies and biomanufacturing subsidiary Velocity Bioworks; highlights Entolimod as key asset.","No dispute or disagreement with Ernst's resignation; Handley's existing employment agreement unchanged from February 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-001461","json":"https://secwatch.observer/filing/0001683168-26-001461.json","markdown":"https://secwatch.observer/filing/0001683168-26-001461.md","text":"https://secwatch.observer/filing/0001683168-26-001461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826001461/0001683168-26-001461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826001461/tivic_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:45:34.833398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}